Adlai Nortye (ANL) Invested Capital (2022 - 2025)
Adlai Nortye (ANL) reported Invested Capital of $18.4 million for Q4 2025, down 65.14% year-over-year from $52.8 million in Q4 2024, and down 58.19% on a QoQ basis from $44.1 million in Q2 2025.
Adlai Nortye (ANL) has 4 years of Invested Capital data on file, last reported at $18.4 million in Q4 2025.
- Quarterly Invested Capital fell 65.14% year-over-year to $18.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $18.4 million (down 65.14% YoY) and the FY2025 annual result came in at $18.4 million, down 65.14% from the prior year.
- Invested Capital declined to $18.4 million in Q4 2025 per ANL's latest filing, from $44.1 million in the prior quarter.
- Across five years, Invested Capital topped out at $106.7 million in Q4 2023 and bottomed at $18.4 million in Q4 2025.
- The 4-year median for Invested Capital is $54.2 million (2022), against an average of $61.7 million.
- The widest annual swing landed in 2023, when Invested Capital jumped 91.83%; it then slumped 65.14% in 2025.
- Tracing ANL's Invested Capital over 4 years: stood at $55.6 million in 2022, then jumped by 91.83% to $106.7 million in 2023, then slumped by 50.48% to $52.8 million in 2024, then tumbled by 65.14% to $18.4 million in 2025.
- Per Business Quant, the three latest ANL Invested Capital figures stand at $18.4 million (Q4 2025), $44.1 million (Q2 2025), and $52.8 million (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | 595,226.00 |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | - |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,282.79 Bn | 2,282.72 Bn | - | 110.96 Mn |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | 14.38 Mn |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | 19.36 Bn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | 31.42 Bn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | 1.08 Bn |
| 10 | Adlai Nortye | 23,840.00 | -8.03 Mn | - | 18.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 18.42 Mn |
| Jun 30, 2025 | 44.05 Mn |
| Dec 31, 2024 | 52.85 Mn |
| Jun 30, 2024 | 92.26 Mn |
| Dec 31, 2023 | 106.71 Mn |
| Dec 31, 2022 | 55.63 Mn |